Guise, A; Witzel, TC; Mandal, S; Sabin, C; Rhodes, T; Nardone, A; Harris, M; (2018) A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK. BMC infectious diseases, 18 (1). p. 281. ISSN 1471-2334 DOI: https://doi.org/10.1186/s12879-018-3185-7

Harris, M; Bonnington, O; Harrison, G; Hickman, M; Irving, W; HepCATT team; , COLLABORATORS; Roberts, K; Waldron, CA; Bevan, J; +37 more... Simpson, C; Homan, C; Reeve, D; Hathaway, C; Purcell, S; Oelbaum, S; Whitfield, J; Jennings, S; Dreha, R; Byrne, T; Thomas, D; Fraser, E; Toyne, K; Newton, P; Hensley, F; Hewish, S; Rutkowski, R; Christian, A; Smith, S; Ward, E; Rhodes, T; Lattimore, S; Mandal, S; Simmons, R; Sreedharan, A; Murray, K; Richardson, P; Caldwell, H; Gore, R; Hughes, A; Walters, C; Orton, A; Lee, P; Ryder, S; Thomson, B; Montgomery, A; Foster, G; (2018) Understanding hepatitis C intervention success-Qualitative findings from the HepCATT study. Journal of viral hepatitis. ISSN 1352-0504 DOI: https://doi.org/10.1111/jvh.12869 Item availability may be restricted.

Harris, M; Brathwaite, R; McGowan, CR; Ciccarone, D; Gilchrist, G; McCusker, M; O'Brien, K; Dunn, J; Scott, J; Hope, V; (2018) 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm reduction journal, 15 (1). p. 23. ISSN 1477-7517 DOI: https://doi.org/10.1186/s12954-018-0233-y

Harris, M; Brathwaite, R; Scott, J; Gilchrist, G; Ciccarone, D; Hope, V; McGowan, CR; (2018) Drawing attention to a neglected injecting-related harm: A systematic review of AA-amyloidosis among people who inject drugs. Addiction (Abingdon, England). ISSN 0965-2140 DOI: https://doi.org/10.1111/add.14257 Item availability may be restricted.

Harris, M; Rhodes, T; (2018) "It's Not Much of a Life": The Benefits and Ethics of Using Life History Methods With People Who Inject Drugs in Qualitative Harm Reduction Research. Qualitative health research. p. 1049732318764393. ISSN 1049-7323 DOI: https://doi.org/10.1177/1049732318764393 Item availability may be restricted.

Harris, M; Rhodes, T; (2018) Caring and curing: Considering the effects of hepatitis C pharmaceuticalisation in relation to non-clinical treatment outcomes. The International journal on drug policy, 60. pp. 24-32. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2018.07.015 Full text not available from this repository.

McGowan, CR; Harris, M; Platt, L; Hope, V; Rhodes, T; (2018) Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it? The International journal on drug policy, 58. pp. 31-36. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2018.04.017

Rhodes, T; Lancaster, K; Harris, M; Treloar, C; (2018) Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination. Critical public health. pp. 1-14. ISSN 0958-1596 DOI: https://doi.org/10.1080/09581596.2018.1459475 Full text not available from this repository.

Bonnington, O; Harris, M; (2017) Tensions in relation: How peer support is experienced and received in a hepatitis C treatment intervention. The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2017.05.031

Grebely, J; Bruneau, J; Bruggmann, P; Harris, M; Hickman, M; Rhodes, T; Treloar, C; International Network on Hepatitis in Substance Users; International Network on Hepatitis in Substance Users; (2017) Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy. The International journal on drug policy, 47. pp. 26-33. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2017.08.001 Full text not available from this repository.

Harris, M; (2017) Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'. The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2017.03.015

Lazarus, JV; Safreed-Harmon, K; Stumo, SR; Jauffret-Roustide, M; Maticic, M; Reic, T; Schatz, E; Tallada, J; Harris, M; Hep-CORE Study Group; (2017) Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses. The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2017.05.054 Full text not available from this repository.

Lazarus, JV; Stumo, SR; Harris, M; Hendrickx, G; Hetherington, KL; Maticic, M; Jauffret-Roustide, M; Tallada, J; Simojoki, K; Reic, T; +2 more... Safreed-Harmon, K; Hep-CORE Study Group; (2017) Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017. Journal of the International AIDS Society, 21 Suppl 2. e25052. ISSN 1758-2652 DOI: https://doi.org/10.1002/jia2.25052

Lewer, D; Harris, M; Hope, V; (2017) Opiate Injection-Associated Skin, Soft Tissue, and Vascular Infections, England, UK, 1997-2016. Emerging infectious diseases, 23 (8). pp. 1400-1403. ISSN 1080-6040 DOI: https://doi.org/10.3201/eid2308.170439

McGowan, CR; Viens, AM; Harris, M; Rhodes, T; (2017) Risk Environments and the Ethics of Reducing Drug-Related Harms. The American journal of bioethics, 17 (12). pp. 46-48. ISSN 1526-5161 DOI: https://doi.org/10.1080/15265161.2017.1388870 Item availability may be restricted.

Harris, M; Ward, E; Gore, C; (2016) Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom. Journal of viral hepatitis. ISSN 1352-0504 DOI: https://doi.org/10.1111/jvh.12513 Full text not available from this repository.

Schatz, E; Schiffer, K; Maher, M; Harris, M; Roca, XM; Maticic, M; Leicht, A; (2016) The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs. Hepatology, medicine and policy, 1 (1). p. 14. ISSN 2059-5166 DOI: https://doi.org/10.1186/s41124-016-0021-9

Ciccarone, D; Harris, M; (2015) Fire in the vein: Heroin acidity and its proximal effect on users' health. The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2015.04.009 Full text not available from this repository.

Harris, M; (2015) "Three in the Room": Embodiment, Disclosure, and Vulnerability in Qualitative Research. Qualitative health research. ISSN 1049-7323 DOI: https://doi.org/10.1177/1049732314566324 Full text not available from this repository.

Harris, M; Albers, E; Swan, T; (2015) The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs? The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2015.05.005 Full text not available from this repository.

Wolfe, D; Luhmann, N; Harris, M; Momenghalibaf, A; Albers, E; Byrne, J; Swan, T; (2015) Human rights and access to hepatitis C treatment for people who inject drugs. The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2015.05.007 Full text not available from this repository.

Harris, M; Forseth, K; Rhodes, T; (2014) "It's Russian roulette": Adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage. The International journal on drug policy, 26 (1). pp. 51-8. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2014.09.009 Full text not available from this repository.

Harris, M; McDonald, B; Rhodes, T; (2014) Hepatitis C testing for people who inject drugs in the United Kingdom: Why is uptake so low? Drugs (Abingdon, England), 21 (4). pp. 333-342. ISSN 0968-7637 DOI: https://doi.org/10.3109/09687637.2014.899988 Full text not available from this repository.

Lazarus, JV; Lundgren, J; Casabona, J; Wiessing, L; Matheï, C; Vickerman, P; Prins, M; Kretzschmar, M; Kantzanou, M; Giraudon, I; +10 more... Ferri, M; Griffiths, P; Harris, M; Walker, M; Chavdarova, L; Schatz, E; Schiffer, K; Kools, JP; Farell, J; Mendão, L; (2014) Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. BMC infectious diseases, 14 (Suppl 6). S18-S18. ISSN 1471-2334 DOI: https://doi.org/10.1186/1471-2334-14-S6-S18

Treloar, C; Gray, R; Brener, L; Jackson, C; Saunders, V; Johnson, P; Harris, M; Butow, P; Newman, C; (2014) “I can’t do this, it’s too much”: building social inclusion in cancer diagnosis and treatment experiences of Aboriginal people, their carers and health workers. International journal of public health, 59 (2). pp. 373-379. ISSN 1661-8556 DOI: https://doi.org/10.1007/s00038-013-0466-1 Full text not available from this repository.

Harris, M; Rhodes, T; (2013) Methadone diversion as a protective strategy: The harm reduction potential of 'generous constraints'. The International journal on drug policy, 24 (6). e43-50. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2012.10.003 Full text not available from this repository.

Treloar, C; Newland, J; Harris, M; Deacon, R; Maher, L; (2010) A diagnosis of hepatitis C: insights from a study on patients' experiences. Australian Family Physican, 39 (8). pp. 589-592. http://researchonline.lshtm.ac.uk/id/eprint/3123 Full text not available from this repository.

Harris, M; (2009) Relapse to injecting drug use: A hepatitis C treatment concern. Contemporary drug problems, 36 (1/2). p. 303. ISSN 0091-4509 http://proquest.umi.com/pqdlink?did=1924268531&Fmt... Full text not available from this repository.